Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Thibaud Lebouvier, Yaohua Chen, Patrick Duriez, Florence Pasquier & Régis Bordet. (2020) Antihypertensive agents in Alzheimer’s disease: beyond vascular protection. Expert Review of Neurotherapeutics 20:2, pages 175-187.
Read now
Read now
Alexander Joost, Heribert Schunkert & Peter Walter Radke. (2011) Candesartan cilexetil: an update. Expert Opinion on Pharmacotherapy 12:11, pages 1769-1780.
Read now
Read now
Thomas Mengden, Sakir Uen & Peter Bramlage. (2009) Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility. Vascular Health and Risk Management 5, pages 1043-1058.
Read now
Read now
Björn Wilgot Karlson, Sofia Zetterstrand, Bertil Olofsson & Dag Elmfeldt. (2009) A dose-response analysis of candesartan-hydrochlorothiazide combination therapy in patients with hypertension. Blood Pressure 18:3, pages 149-156.
Read now
Read now
Maria G. Pavlatou, George Mastorakos, Ioannis Lekakis, Stavros Liatis, Georgia Vamvakou, Emmanuel Zoumakis, Ioannis Papassotiriou, Andreas D. Rabavilas, Nikolaos Katsilambros & George P. Chrousos. (2008) Chronic administration of an angiotensin II receptor antagonist resets the hypothalamic–pituitary–adrenal (HPA) axis and improves the affect of patients with diabetes mellitus type 2: Preliminary results. Stress 11:1, pages 62-72.
Read now
Read now
Articles from other publishers (37)
F. Bompaire, C. Birzu, K. Bihan, V. Desestret, G. Fargeot, A. Farina, B. Joubert, D. Leclercq, L. Nichelli, A. Picca, C. Tafani, N. Weiss, D. Psimaras & D. Ricard. (2023) Advances in treatments of patients with classical and emergent neurological toxicities of anticancer agents. Revue Neurologique 179:5, pages 405-416.
Crossref
Crossref
Marco Antônio Peliky Fontes, Lucas M. Kangussu & Ana Cristina Simões-e-Silva. 2023. Angiotensin. Angiotensin
623
640
.
Corinna Doege, Mark Luedde & Karel Kostev. (2022) Association Between Angiotensin Receptor Blocker Therapy and Incidence of Epilepsy in Patients With Hypertension. JAMA Neurology 79:12, pages 1296.
Crossref
Crossref
Michelle Canavan & Martin J. O'Donnell. (2022) Hypertension and Cognitive Impairment: A Review of Mechanisms and Key Concepts. Frontiers in Neurology 13.
Crossref
Crossref
Robert Terziev, Dimitri Psimaras, Yannick Marie, Loic Feuvret, Giulia Berzero, Julian Jacob, Caroline Dehais, Flavie Bompaire, Wolf Mueller, Ben Kinnersley, Jean-Yves Delattre, Ahmed Idbaih, Khe Hoang-Xuan, Marc Sanson & Damien Ricard. (2021) Cumulative incidence and risk factors for radiation induced leukoencephalopathy in high grade glioma long term survivors. Scientific Reports 11:1.
Crossref
Crossref
Juan M. Saavedra. (2021) Angiotensin Receptor Blockers Are Not Just for Hypertension Anymore. Physiology 36:3, pages 160-173.
Crossref
Crossref
Antonia V. Seligowski, Lucie A. Duffy, Julia B. Merker, Vasiliki Michopoulos, Charles F. Gillespie, Paul J. Marvar, Murray B. Stein & Kerry J. Ressler. (2020) The renin–angiotensin system in PTSD: a replication and extension. Neuropsychopharmacology 46:4, pages 750-755.
Crossref
Crossref
Ehab Farag, Chen Liang, Edward J. Mascha, Maged Y. Argalious, Jacob Ezell, Kamal Maheshwari, Wael Ali Sakr Esa, Christopher A. Troianos & Daniel I. Sessler. (2020) Association between Use of Angiotensin-converting Enzyme Inhibitors or Angiotensin Receptor Blockers and Postoperative Delirium. Anesthesiology 133:1, pages 119-132.
Crossref
Crossref
Abdel G. Elkahloun & Juan M. Saavedra. (2019) Candesartan Neuroprotection in Rat Primary Neurons Negatively Correlates with Aging and Senescence: a Transcriptomic Analysis. Molecular Neurobiology 57:3, pages 1656-1673.
Crossref
Crossref
Keren Asraf, Nofar Torika, Ron N. Apte & Sigal Fleisher-Berkovich. (2018) Microglial Activation Is Modulated by Captopril: in Vitro and in Vivo Studies. Frontiers in Cellular Neuroscience 12.
Crossref
Crossref
Urmila Aswar, Shilpa Chepurwar, Sumit Shintre & Manoj Aswar. (2017) Telmisartan attenuates diabetes induced depression in rats. Pharmacological Reports 69:2, pages 358-364.
Crossref
Crossref
I. Sebastião, E. Candeias, M. S. Santos, C. R. Oliveira, Paula I. Moreira & Ana I. Duarte. 2017. Neuroprotective Therapy for Stroke and Ischemic Disease. Neuroprotective Therapy for Stroke and Ischemic Disease
711
731
.
Juan M. Saavedra. (2016) Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer’s Disease. Cellular and Molecular Neurobiology 36:2, pages 259-279.
Crossref
Crossref
Xiu-Li Yang, Chi Kyung Kim, Tae Jung Kim, Jing Sun, Doeun Rim, Young-Ju Kim, Sang-Bae Ko, Hyunduk Jang & Byung-Woo Yoon. (2015) Anti-inflammatory effects of fimasartan via Akt, ERK, and NFκB pathways on astrocytes stimulated by hemolysate. Inflammation Research 65:2, pages 115-123.
Crossref
Crossref
Sonia Villapol, María G. Balarezo, Kwame Affram, Juan M. Saavedra & Aviva J. Symes. (2015) Neurorestoration after traumatic brain injury through angiotensin II receptor blockage. Brain 138:11, pages 3299-3315.
Crossref
Crossref
Sonia Villapol & Juan M. Saavedra. (2015) Neuroprotective Effects of Angiotensin Receptor Blockers. American Journal of Hypertension 28:3, pages 289-299.
Crossref
Crossref
John W. Wright, Leen H. Kawas & Joseph W. Harding. (2015) The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases. Progress in Neurobiology 125, pages 26-46.
Crossref
Crossref
Astrid G. HornslienElse C. SandsetPhilip M. BathTorgeir B. WyllerEivind Berge. (2013) Effects of Candesartan in Acute Stroke on Cognitive Function and Quality of Life. Stroke 44:7, pages 2022-2024.
Crossref
Crossref
Sonia Villapol, Alexandra K Yaszemski, Trevor T Logan, Enrique Sánchez-Lemus, Juan M Saavedra & Aviva J Symes. (2012) Candesartan, an Angiotensin II AT1-Receptor Blocker and PPAR-γ Agonist, Reduces Lesion Volume and Improves Motor and Memory Function After Traumatic Brain Injury in Mice. Neuropsychopharmacology 37:13, pages 2817-2829.
Crossref
Crossref
Juan M. Saavedra. (2012) Angiotensin II AT1 receptor blockers as treatments for inflammatory brain disorders. Clinical Science 123:10, pages 567-590.
Crossref
Crossref
Juan M. Saavedra. (2011) Angiotensin II AT1 Receptor Blockers Ameliorate Inflammatory Stress: A Beneficial Effect for the Treatment of Brain Disorders. Cellular and Molecular Neurobiology 32:5, pages 667-681.
Crossref
Crossref
Hanna Andersson & Mathias Hallberg. (2012) Discovery of Inhibitors of Insulin-Regulated Aminopeptidase as Cognitive Enhancers. International Journal of Hypertension 2012, pages 1-18.
Crossref
Crossref
Juan M. Saavedra, Enrique Sánchez-Lemus & Julius Benicky. (2011) Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications. Psychoneuroendocrinology 36:1, pages 1-18.
Crossref
Crossref
Dina Zekry & Gabriel Gold. (2010) Management of Mixed Dementia. Drugs & Aging 27:9, pages 715-728.
Crossref
Crossref
Reinhard Ketelhut & Peter Bramlage. (2012) Candesartan Cilexetil/Hydrochlorothiazide Treatment in High-Risk Patients with Type 2 Diabetes Mellitus and Microalbuminuria. Clinical Drug Investigation 30:5, pages 301-311.
Crossref
Crossref
Peter Bramlage, Eleonore Schönrock & Peter Odoj. (2008) Metabolic effects of an AT1-receptor blockade combined with HCTZ in cardiac risk patients: a non interventional study in primary care. BMC Cardiovascular Disorders 8:1.
Crossref
Crossref
John W WrightJoseph W Harding. (2008)
The angiotensin AT
4
receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease
. Journal of the Renin-Angiotensin-Aldosterone System 9:4, pages 226-237.
Crossref
Crossref
Jan W. ErikssonPer-Anders JanssonBo CarlbergAnders HäggLisa KurlandMaria K. SvenssonHåkan AhlströmConny StrömLars LönnKristina ÖjbrandtLars JohanssonLars Lind. (2008) Hydrochlorothiazide, but not Candesartan, Aggravates Insulin Resistance and Causes Visceral and Hepatic Fat Accumulation. Hypertension 52:6, pages 1030-1037.
Crossref
Crossref
E. Kim, M. H. Cho, K. R. Cha, J. S. Park, C-W. Ahn, B. H. Oh & C-H. Kim. (2008) Interactive effect of central obesity and hypertension on cognitive function in older out-patients with Type 2 diabetes. Diabetic Medicine 25:12, pages 1440-1446.
Crossref
Crossref
Mehmet Ozaydin, Ozkan Dede, Ercan Varol, Sahin Kapan, Yasin Turker, Oktay Peker, Harun Duver & Erdogan Ibrisim. (2008) Effect of renin–angiotensin aldosteron system blockers on postoperative atrial fibrillation. International Journal of Cardiology 127:3, pages 362-367.
Crossref
Crossref
K. Sakakura, S. Hoshide, J. Ishikawa, S.-i. Momomura, M. Kawakami, K. Shimada & K. Kario. (2008) Association of Body Mass Index With Cognitive Function in Elderly Hypertensive Japanese. American Journal of Hypertension 21:6, pages 627-632.
Crossref
Crossref
V. H. Taylor & G. M. MacQueen. (2007) Cognitive dysfunction associated with metabolic syndrome. Obesity Reviews 8:5, pages 409-418.
Crossref
Crossref
G.K. Aulakh, R.K. Sodhi & M. Singh. (2007) An update on non-peptide angiotensin receptor antagonists and related RAAS modulators. Life Sciences 81:8, pages 615-639.
Crossref
Crossref
. (2007) Current awareness in geriatric psychiatry. International Journal of Geriatric Psychiatry 22:1, pages 91-98.
Crossref
Crossref
Patricio López-Jaramillo, Lina P Pradilla, Vicente Lahera, Federico A Silva Sieger, Christian F Rueda-Clausen & Gustavo A Márquez. (2006) A randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity. "ARAMIA". Trials 7:1.
Crossref
Crossref
Karen Ritchie & Florence Portet. (2006) ‘I think therefore I am’: improving cognition. Current Opinion in Psychiatry 19:6, pages 570-574.
Crossref
Crossref
Greg L Plosker & Susan J Keam. (2006) Candesartan Cilexetil. PharmacoEconomics 24:12, pages 1249-1272.
Crossref
Crossref